Therefore, the proposed analysis of the genetic status may facilitate the identification of mutations in the SMAD4 gene as a novel diagnostic marker or therapeutic target in HNSCC and other head and neck cancers. This evidence concerns the gene SMAD4 and head and neck cancer.